Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Metabolic Syndrome: full-pipeline trial registry
28 of 104 indexed Metabolic Syndrome trials are currently recruiting.
Corpus placement: #129 of 28,707 conditions by registered trial count.
104 US clinical trials · 28 currently recruiting · #129 of 28,707 conditions by registered trial count
Metabolic Syndrome: 104 US clinical trials tracked, 28 recruiting.
Metabolic Syndrome is the subject of 104 registered US clinical trials on ClinicalTrials.gov, 28 of them currently open to new participants. 7 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Davis, running 5 of these trials.
Enrollment posture brief
Registry condition metabolic-syndrome
OPEN 28 | RECR 27% | LATE 7 | EARLY 9 | RANK #129 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Cancer Survivor (27% recruiting · 26 trials)
Metabolic Syndrome lists 28 open slots (27% of 104 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Metabolic Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Metabolic Syndrome is recruiting below its size-band peers.
28 of 104 indexed trials (26.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Metabolic Syndrome trials is spread across many organizations.
University of California, Davis accounts for 5 of 104 trials (4.8%). 80 distinct sponsors appear on at least one study for this condition label.
-
Most Metabolic Syndrome trials plan to enrol fewer than 100 people.
Median target enrolment is 55 among the 103 trials that report a genuine target (sentinel values excluded). 70 of those (68%) plan for fewer than 100 participants.
-
Metabolic Syndrome research is mostly interventional.
88 interventional and 16 observational studies make up this index (84.6% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
104 total, page 3 of 3
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
Baylor University
NCT04498455
Virtual Enhanced Lifestyle for Metabolic Syndrome (ELM) Proof-of-Concept Study
Rush University Medical Center
NCT04637477
Effects of Human Leptin Replacement
University of Miami
NCT00657605
Effect of Rosiglitazone in Nondiabetic Patients With the Metabolic Syndrome
University of Colorado, Denver
NCT00364221
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 6 |
| Phase 3 | 1 |
| Phase 4 | 6 |
Top Sponsors
Named interventions
Most-linked intervention names on Metabolic Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Metabolic Syndrome trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Metabolic Syndrome page
104 registered trials, 28 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 28 Metabolic Syndrome trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, Davis sponsors the most Metabolic Syndrome trials on record, review their full trial history before evaluating a specific study. See University of California, Davis's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Metabolic Syndrome condition card totals 104 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.